Additional €122 million for coronavirus research and innovation

20/05/2020
The Commission has mobilised another €122 million from its research and innovation programme, Horizon 2020, for urgently needed research into the coronavirus. The new call for expressions of interest contributes to the Commission's €1.4 billion pledge to the Coronavirus Global Response initiative, launched by President Ursula von der Leyen on 4 May 2020.

The new call is the newest addition to a range of EU-funded research and innovation actions to fight the coronavirus which complements earlier actions to develop diagnostics, treatments and vaccines by strengthening capacity to manufacture and deploying available solutions in order to address the needs. It will also improve understanding of the behavioural and socio-economic impacts of the epidemic.

The projects funded under this call should repurpose manufacturing for rapid production of medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care. Europe, and the world, urgently need innovative solutions to mitigate the outbreak, and to better care for patients, survivors, vulnerable groups, frontline health care staff and their communities. New research will learn from large groups of patients (cohorts) across Europe and better understanding of the behavioural and socio-economic impacts of the coronavirus epidemic could help improve treatment and prevention strategies.

The deadline for submission is 11 June 2020

The new solutions need to be available and affordable for all, in line with the principles of the Coronavirus Global Response. For this purpose, the Commission will include rapid data-sharing clauses in grant agreements, resulting from this new call, to ensure that findings and outcomes can be put to use immediately.

Five areas for budgets distribution

The new call will cover five areas with the following indicative budgets:

  1. Repurposing of manufacturing for vital medical supplies and equipment (€23 million)
  2. Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
  3. Behavioural, social and economic impacts of the outbreak responses (€20 million)
  4. Pan-European COVID-19 cohorts (€20 million)
  5. Collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)

Previous COVID19 calls

This new special call under Horizon 2020 complements earlier actions to support 18 projects with €48.2 million to develop diagnostics, treatments, vaccines and preparedness for epidemics, as well as the €117 million invested in 8 projects on diagnostics and treatments through the Innovative Medicines Initiative, and measures to support innovative ideas through the European Innovation Council. It implements Action 3 of the ERAvsCorona Action Plan, a working document resulting from dialogues between the Commission services and national institutions.

Are you interested with all content related to "R&D&I funding"?

Subscribe you to our newsletter and we will keep you updated to the latest news

Read more:

You may also be interested in:

28/05/2020
The four calls of the EU Secure Societies programme opened on 12 March 2020. If you are working on a project involving infrastructure protection, digital security or artificial intelligence, read on!
28/05/2020
The European Commission has proposed a €750 billion recovery fund which includes a grant facility of up to € 310 billion and € 250 billion in loans.
27/05/2020
You can participate in the public consultation launched by the European Commission to shape a new H2020 call on the European Green Deal.